Alpha 2.0
Login Register
» Articles » PMID: 32580936

Why Covid-19 Antibody Tests Are Not the Game Changer the UK Government Claims

Overview
Journal BMJ
Specialty General Medicine
Date 2020 Jun 26
PMID 32580936
Citations 3
Authors
Stephen Armstrong
Affiliations
Soon will be listed here.
Citing Articles

Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic wave.

Sweeney N, Merrick B, Galao R, Pickering S, Botgros A, Wilson H PLoS One. 2021; 16(4):e0249791.

PMID: 33826651 PMC: 8026061. DOI: 10.1371/journal.pone.0249791.

Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers.

Robinson A, Weaving G, Philips B, Eziefula A, Shipman K, Chevassut T Clin Med (Lond). 2021; 21(3):e300-e305.

PMID: 33727368 PMC: 8140713. DOI: 10.7861/clinmed.2020.1007.

Public understanding of COVID-19 antibody testing and test results: A qualitative study conducted in the U.K. early in the pandemic.

Lecouturier J, Kelly M, Graham F, Meyer C, Tang M, Goffe L Soc Sci Med. 2021; 273:113778.

PMID: 33636445 PMC: 7884253. DOI: 10.1016/j.socscimed.2021.113778.